- Home
- STRO vs MCR Comparison
STRO vs MCR Comparison
Compare STRO & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- MCR
- Stock Information
- Founded
- STRO 2003
- MCR 1989
- Country
- STRO United States
- MCR United States
- Employees
- STRO N/A
- MCR N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- MCR Trusts Except Educational Religious and Charitable
- Sector
- STRO Health Care
- MCR Finance
- Exchange
- STRO Nasdaq
- MCR Nasdaq
- Market Cap
- STRO 77.7M
- MCR 250.1M
- IPO Year
- STRO 2018
- MCR N/A
- Fundamental
- Price
- STRO $0.76
- MCR $6.40
- Analyst Decision
- STRO Hold
- MCR
- Analyst Count
- STRO 7
- MCR 0
- Target Price
- STRO $3.97
- MCR N/A
- AVG Volume (30 Days)
- STRO 1.4M
- MCR 66.7K
- Earning Date
- STRO 08-12-2025
- MCR 01-01-0001
- Dividend Yield
- STRO N/A
- MCR 8.52%
- EPS Growth
- STRO N/A
- MCR N/A
- EPS
- STRO N/A
- MCR 0.38
- Revenue
- STRO $66,434,000.00
- MCR N/A
- Revenue This Year
- STRO N/A
- MCR N/A
- Revenue Next Year
- STRO N/A
- MCR N/A
- P/E Ratio
- STRO N/A
- MCR $16.61
- Revenue Growth
- STRO N/A
- MCR N/A
- 52 Week Low
- STRO $0.52
- MCR $5.63
- 52 Week High
- STRO $5.17
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- STRO 44.92
- MCR 65.06
- Support Level
- STRO $0.67
- MCR $6.32
- Resistance Level
- STRO $0.79
- MCR $6.41
- Average True Range (ATR)
- STRO 0.07
- MCR 0.05
- MACD
- STRO -0.01
- MCR 0.01
- Stochastic Oscillator
- STRO 34.52
- MCR 78.95
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.